Results 51 to 60 of about 3,017,330 (266)

Sustained Therapeutic Efficacy of Intravenous Plasminogen Concentrate in Pediatric Patients With Type 1 Plasminogen Deficiency: An Analysis of Dosing Parameters and Clinical Outcomes

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Type 1 plasminogen deficiency (PLGD‐1) is an ultra‐rare autosomal recessive disorder caused by variants in the PLG gene and affects approximately 1.6 individuals per million. The condition is characterized by decreased plasminogen levels and impaired function, resulting in fibrin‐rich lesions on mucous membranes throughout the body.
Charles Nakar   +7 more
wiley   +1 more source

Rational Use of Herbal Products in Pediatric Patients Treated With Anticancer Drugs in the European Union

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction The use of herbal medical preparation (HMP) is rising among pediatric oncology patients, often to manage treatment‐related symptoms. Their effectiveness remains uncertain, and the risk of herb–drug interactions is underestimated.
Orianne Mahot   +6 more
wiley   +1 more source

Appraisal of Significance of Acoustic Parameters in Contribution to Human Annoyance

open access: yesApplied Sciences, 2020
The goal of this paper was to describe a study which aimed to determine the significance of acoustic parameters in terms of some typical audio signals which occur in common urban environments. The focus when establishing the significance was set on their
Mia Suhanek   +3 more
doaj   +1 more source

Improved Early Referral in Long‐Term Survivor Care With Institutional Standardized Practice Among Childhood Leukemia Survivors#

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT In 2018, the Texas Children's Cancer and Hematology Center Leukemia Program implemented a practice standard to support the transition from treatment to survivorship that includes shared, alternating care between leukemia and survivorship clinicians and a reminder to refer survivors to the long‐term survivor clinic (LTSC) 2 years after ...
Ji Yun Tark   +9 more
wiley   +1 more source

Personalized Zebrafish Models for Fusion‐Positive Pediatric Sarcomas

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Clinical sequencing efforts have revolutionized our approaches to categorizing pediatric cancers in real time. This has dramatically improved our ability to profile pediatric tumors, identify actionable vulnerabilities, and influence clinical care.
Lisa H. Hall   +2 more
wiley   +1 more source

Beyond Dualism and Monism: Bergson's Slanted Being

open access: yesJournal of French and Francophone Philosophy, 2016
There is an old but still unresolved debate pertaining to the question of Bergsonian monism or dualism.  Scholars who think that Bergson is ultimately monist clash with those who claim that he has consistently maintained a dualist position.
Messay Kebede
doaj   +1 more source

The Role of “Adult‐Onset” Cancer Predisposition Genes in Pediatric Cancer: A Comprehensive Review

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Current literature estimates that 10% of pediatric cancers are caused by pathogenic or likely pathogenic (P/LP) germline variants in cancer predisposition genes (CPGs). Variants in CPGs thought to increase cancer risk exclusively during adulthood are referred to as “adult‐onset” CPGs (aoCPGs).
Maria Rozo   +5 more
wiley   +1 more source

Bergson : événement et création

open access: yesMethodos, 2017
Just like Humpty Dumpty, the character of Lewis Carroll who celebrates his non-birthday 364 days a year, Bergson seems to inscribe discontinuity of event in the continuity of duration.
Armel Mazeron
doaj   +1 more source

Calculation of certain bonds duration on the financial market of Bosnia and Herzegovina [PDF]

open access: yesBankarstvo, 2014
Duration is the main measure of price sensitivity which is used on the bond market. It indicates how much the bond price would change under the impact of change in the market interest rates.
Alihodžić Almir
doaj   +1 more source

Home - About - Disclaimer - Privacy